Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study

Impact of Sacubitril/Valsartan on Clinical and Echocardiographic Parameters in Heart Failure Patients With Reduced Ejection Fraction: Data From a Real Life 2-year Follow-Up Study

Heart failure (HF) represents a widespread health problem characterized by high morbidity and mortality. Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients affected by HF with reduced ejection fraction (HFrEF). The aim of this study was to evaluate the effectiveness and durab...

Full description

Bibliographic Details
Main Authors: Giuseppe Armentaro, Graziella D’Arrigo, Marcello Magurno, Alfredo F. Toscani, Valentino Condoleo, Sofia Miceli, Velia Cassano, Raffaele Maio, Franco Arturi, Giovanni Tripepi, Giorgio Sesti, Angela Sciacqua
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Pharmacology
Subjects:
heart failure
sacubitril/valsartan
cardiac index
left ventricular ejection fraction
NT-proBNP
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.733475/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.733475/full

Similar Items